No results for ‘’
Shukra Pharmaceuticals Ltd
₹30.98
(2.79%)
Mon, 15 Jun 2026, 10:31 am
Health Technology
Pharmaceuticals: Major
24.5KShukra Pharmaceuticals Return on Equity (ROE) History
| Particulars | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Price to earnings ratio | 37.35 | 12.62 | 1.79 | 19.29 | 99.91 |
| Price to book ratio | 0.45 | 0.58 | 2.03 | 6.20 | 15.23 |
| Price to sales ratio | 0.61 | 0.46 | 0.13 | 4.79 | 29.36 |
| Price to cash flow ratio | 11.93 | 1.26 | 2.65 | 0 | 108.69 |
| Enterprise value | 16.23Cr | 12.75Cr | 9Cr | 351Cr | 949Cr |
| Enterprise value to EBITDA ratio | 9.49 | 4.40 | 1.39 | 18.03 | 74.44 |
| Debt to equity ratio | 0.63 | 0.21 | 0.20 | 0.05 | 0.07 |
| Return on equity % | 0 | 4.70 | 21.16 | 44.70 | 15.90 |
Shukra Pharmaceuticals Ltd Return on Equity
The Shukra Pharmaceuticals Ltd Return on Equity is a key financial metric used by investors to evaluate Shukra Pharmaceuticals Ltd's valuation, profitability, and overall financial performance. Tracking the Shukra Pharmaceuticals Ltd Return on Equity helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Shukra Pharmaceuticals Ltd (NSE: , BSE: 524632) is currently trading at ₹30.98, with a market capitalization of ₹1395.52Cr. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the Shukra Pharmaceuticals Ltd Return on Equity is essential for fundamental analysis.
Shukra Pharmaceuticals Ltd Return on Equity Current Value
The current Shukra Pharmaceuticals Ltd Return on Equity stands at 15.90.
The Shukra Pharmaceuticals Ltd Return on Equity has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.
Shukra Pharmaceuticals Ltd Return on Equity Historical Trend
The Shukra Pharmaceuticals Ltd Return on Equity has shown the following historical trend:
- 2024: 15.90
- 2023: 44.70
- 2022: 21.16
- 2021: 4.70
- 2020: 0
The decline in Shukra Pharmaceuticals Ltd Return on Equity indicates improving financial efficiency or better earnings growth.
What Shukra Pharmaceuticals Ltd Return on Equity Indicates for Investors
The Shukra Pharmaceuticals Ltd Return on Equity plays a crucial role in understanding the company's financial health and valuation.
ROE indicates how efficiently the company generates returns for shareholders.
Shukra Pharmaceuticals Ltd Return on Equity Analysis Summary
The Shukra Pharmaceuticals Ltd Return on Equity remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Shukra Pharmaceuticals Ltd Return on Equity should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Shukra Pharmaceuticals Ltd Return on Equity helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.